Micro Chemicals
Market Cap
₹1,497 ₹1,497 Cr.
P/E
14.50
PEG
2.01
PEG = P/E ÷ 5yr Forward EPS CAGR
5yr Forward EPS CAGR Thesis - Base Case

- The thesis becomes more credible if the Gelatin expansion and near-full Collagen Peptide capacity convert into recurring demand, with FY27 Collagen Peptide, DCP realization and export sales as key read-throughs.- The bull path requires faster Collagen Peptide demand and improved DCP realization, while the bear path is triggered by export weakness, raw-material inflation or disappointing conversion.
- Margin performance will shape the earnings outcome as scale and cost controls offset lower Gelatin prices, freight pressure and competitive constraints.

Key Ratios

Debt to Equity
Debt to Equity
0.01
Div Yield (%)
Div Yield (%)
0.42
Individual < 2 lac
Individual < 2 lac
18.45 %
Institutions
Institutions
1.00 %
Market cap
Market cap
1,497 Cr
No. of Shareholders
No. of Shareholders
11,285
OPM (%)
OPM (%)
24.30 %
PE
PE
14.50
Prom Holding
Prom Holding
74.48 %
ROCE (%)
ROCE (%)
25.76
ROE (%)
ROE (%)
19.02
Sales
Sales
590 Cr
  • Nitta Gelatin India
  • Manali Petrochemical
  • Sigachi Industries
  • TJI Speciality Chemicals
Last updated on 8 Jul 2026
  • Nitta Gelatin makes gelatin, ossein, DCP and bovine/fish collagen peptide; ~60% India, ~40% Japan, USA, Asia.
  • Exiting ossein/DCP subsidiary Bamni via liquidation after 2024 shutdown; that revenue stream ends.
  • Earnings from gelatin/ossein/DCP base (~85% of revenue); collagen peptide (~15%) is growth vector; operating leverage and cost controls aid margins.
  • 3.5 TPD collagen peptide plant online; gelatin expansion underway.
  • Net cash despite heavy expansion spend; working capital creep as receivables outpace revenue.
  • Customs demand of ₹18.2Cr stayed by Supreme Court; adverse ruling risks ~10% of net worth.
  • Gelatin expansion commissioning by Q2FY27
    new gelatin capacity comes online.
  • Customs duty appeal No timeline
    decides ₹18.2Cr demand plus ₹10.9Cr penalty.
  • Bamni Proteins asset sale No timeline
    sets sale price against ₹530 Lakhs carrying value.
  • Labour codes finalisation No timeline
    fixes incremental liability beyond ₹226 Lakhs provision.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
765
52W Range
High
2088
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Asset Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Nitta Gelatin India Ltd. Business

Nitta Gelatin India manufactures and sells a range of products including Gelatin, Ossein, DCP, and Collagen Peptide. Their product range caters to various industries such as pharmaceutical, food, agriculture, and industrial applications. With more than 60% exports, they serve customers globally.

Nitta Gelatin India major competitors are Manali Petrochemical, Sigachi Industries, Indo Borax & Chem., Citurgia Biochem., Meghmani Organics, DCW, IG Petrochemicals.
Market Cap of Nitta Gelatin India is ₹1,497 Crs.
While the median market cap of its peers are ₹1,461 Crs.

Nitta Gelatin India seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Nitta Gelatin India Ltd.
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material